Stockscreener 앱 받기
191.31
2.27%
4.25
시간 외 거래:
191.31
전일 마감가:
$187.06
열려 있는:
$187.78
하루 거래량:
383.10K
Relative Volume:
1.71
시가총액:
$3.75B
수익:
$152.42M
순이익/손실:
$45.24M
주가수익비율:
76.22
EPS:
2.51
순현금흐름:
$6.97M
1주 성능:
+2.32%
1개월 성능:
+8.00%
6개월 성능:
+74.14%
1년 성능:
+80.99%
1일 변동 폭
$186.45
$192.83
1주일 범위
$182.87
$194.44
52주 변동 폭
$93.58
$194.44
리간드 파마 Stock (LGND) Company Profile
명칭
Ligand Pharmaceuticals Inc
전화
858-550-7500
주소
3911 SORRENTO VALLEY BLVD, SAN DIEGO, CA
LGND을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LGND
Ligand Pharmaceuticals Inc
|
191.31 | 3.65B | 152.42M | 45.24M | 6.97M | 2.51 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
리간드 파마 Stock (LGND) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-10 | 개시 | Stifel | Buy |
| 2024-10-03 | 개시 | Oppenheimer | Outperform |
| 2024-07-30 | 개시 | RBC Capital Mkts | Outperform |
| 2021-04-14 | 재개 | Stephens | Overweight |
| 2021-02-04 | 재확인 | H.C. Wainwright | Buy |
| 2020-10-06 | 개시 | Barclays | Overweight |
| 2020-03-24 | 다운그레이드 | Argus | Buy → Hold |
| 2020-03-10 | 개시 | Guggenheim | Neutral |
| 2020-02-06 | 개시 | The Benchmark Company | Buy |
| 2019-09-19 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2019-06-11 | 개시 | Barclays | Equal Weight |
| 2019-05-03 | 재확인 | H.C. Wainwright | Buy |
| 2019-03-06 | 재확인 | H.C. Wainwright | Buy |
| 2018-10-29 | 업그레이드 | ROTH Capital | Neutral → Buy |
| 2018-10-02 | 재확인 | H.C. Wainwright | Buy |
| 2018-09-11 | 재확인 | Argus | Buy |
| 2018-08-17 | 개시 | Goldman | Neutral |
| 2018-08-08 | 다운그레이드 | ROTH Capital | Buy → Neutral |
| 2018-06-21 | 개시 | Argus | Buy |
| 2017-12-27 | 재확인 | H.C. Wainwright | Buy |
| 2017-09-05 | 재개 | H.C. Wainwright | Buy |
| 2016-10-05 | 재확인 | H.C. Wainwright | Buy |
| 2016-08-05 | 다운그레이드 | Deutsche Bank | Hold → Sell |
| 2016-03-11 | 개시 | Sidoti | Buy |
| 2016-03-03 | 개시 | H.C. Wainwright | Buy |
모두보기
리간드 파마 주식(LGND)의 최신 뉴스
Does Ligand Pharmaceuticals Incorporated show high probability of reboundWeekly Stock Analysis & Daily Growth Stock Investment Tips - newser.com
Is Ligand Pharmaceuticals Incorporated reversing from oversold territoryWeekly Loss Report & Weekly Hot Stock Watchlists - newser.com
Short interest data insights for Ligand Pharmaceuticals IncorporatedInsider Buying & Stock Portfolio Risk Control - newser.com
What moving averages say about Ligand Pharmaceuticals IncorporatedWatch List & Verified Momentum Stock Alerts - newser.com
What catalysts could drive Ligand Pharmaceuticals Incorporated stock higherWeekly Stock Summary & Consistent Growth Equity Picks - newser.com
Will Ligand Pharmaceuticals Incorporated (LGDN) stock announce a stock splitWall Street Watch & Free Daily Entry Point Trade Alerts - newser.com
Is Ligand Pharmaceuticals Incorporated (LGDN) stock attractive post correction2025 Performance Recap & Fast Entry High Yield Tips - newser.com
Intraday pattern recognizer results for Ligand Pharmaceuticals Incorporated2025 Top Gainers & Free High Return Stock Watch Alerts - newser.com
Analyzing drawdowns of Ligand Pharmaceuticals Incorporated with statistical toolsBull Run & Technical Confirmation Trade Alerts - newser.com
How Ligand Pharmaceuticals Incorporated (LGDN) stock compares with market leaders2025 Earnings Impact & Reliable Price Action Trade Plans - newser.com
Technical signs of recovery in Ligand Pharmaceuticals Incorporated2025 Trade Ideas & Fast Gain Stock Tips - newser.com
What institutional flow reveals about Ligand Pharmaceuticals IncorporatedMarket Risk Summary & Technical Buy Zone Confirmations - newser.com
Is Ligand Pharmaceuticals Incorporated forming a reversal patternJuly 2025 Closing Moves & AI Forecasted Stock Moves - newser.com
Can Ligand Pharmaceuticals Incorporated stock sustain market leadershipAnalyst Downgrade & Long Hold Capital Preservation Tips - newser.com
Ligand Faces Pivotal Week with Earnings and Investor Meetings () - aktiencheck.de
Ligand to Participate in November Investor Conferences - The Manila Times
Ligand (NASDAQ: LGND) to join UBS, Stifel, IDEAS conferences; fireside chat Nov 12 - Stock Titan
Ligand Pharmaceuticals (LGND) Expected to Announce Quarterly Earnings on Thursday - MarketBeat
Will Ligand Pharmaceuticals Incorporated outperform the marketJuly 2025 Retail & Weekly High Return Stock Opportunities - newser.com
Ligand Pharmaceuticals IncorporatedEquity Right (LGNZZ) Price Target Decreased by 44.49% to 0.08 - Nasdaq
Ligand Pharmaceuticals Reaches Analyst Target Price - Nasdaq
What analyst consensus says on Ligand Pharmaceuticals Incorporated stockWeekly Risk Summary & Free Daily Entry Point Trade Alerts - newser.com
Can technical indicators confirm Ligand Pharmaceuticals Incorporated’s reversalQuarterly Market Review & Community Consensus Trade Signals - newser.com
Why Ligand Pharmaceuticals Incorporated stock is a value investor pickJuly 2025 Chart Watch & Real-Time Stock Entry Alerts - fcp.pa.gov.br
Published on: 2025-10-30 23:37:05 - newser.com
리간드 파마 (LGND) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.62%
0.21%
자본화:
|
볼륨(24시간):